Architect Therapeutics
2 known investors
Architect Therapeutics is a drug discovery company that uses C-H bond activation chemistry to synthesize novel 3D small-molecule scaffolds and screen them against difficult-to-drug targets. It develops oral therapies with an emphasis on immunology and oncology.
BiotechDeep Tech
Founders & leadership
JY
Jin-Quan YuFounder
Investors · 2
In the news
Frequently asked questions
- What does Architect Therapeutics do?
- Architect Therapeutics is a drug discovery company that uses C-H bond activation chemistry to synthesize novel 3D small-molecule scaffolds and screen them against difficult-to-drug targets. It develops oral therapies with an emphasis on immunology and oncology.
- Who founded Architect Therapeutics?
- Architect Therapeutics was founded by Jin-Quan Yu.
- Who are Architect Therapeutics's investors?
- Architect Therapeutics's investors include Frazier Life Sciences, OrbiMed.